pocketful logo
Krebs Biochemicals & Industries Ltd logo

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO BSE: 524518

₹57.04

(-4.65%)

Wed, 04 Mar 2026, 11:05 pm

mtf coin illustrationMTF 5x

Company History

1992

  • The company was incorporated on 8th May with the purpose of implementing a 100% EOU project to manufacture pseudoephedrine.
  • The company entered into an agreement for obtaining technology/process known-how from CDRI.

1994

  • A drug licence was obtained in July and exports commenced.
  • The company issued and allotted 3,800,300 No. of equity shares of Rs 10 each through a prospectus.

1996

  • Operations were affected by a cyclone with snapping ST power lines, diesel storage, etc.
  • The company undertook to set up a new project to produce Monosodium Glutamate at a cost of Rs 26.50 crores at Kolhapalli village, Kasimkota Mandal, Visakhapatanam, Andhra Pradesh.
  • The company proposed to issue 14,00,000 warrants to the core promoter and associates.

1997

  • The new ETP facility at Regadichilak was commissioned at a cost of Rs 215 lakhs.
  • Krebs Biochemicals Ltd was setting up a new project to produce monosodium glutamate with an installed capacity of 5,000 tonnes per annum at a capital outlay of Rs.26.50 crores.

1998

  • The company began with an initial capacity of 100,000 tpa and expanded it to 150,000 tpa in 1996.
  • The company viewed the proposed MSG project as economically unviable due to the prevailing currency crisis in South-East Asian countries.
  • KBL was setting up a 5,000 tonnes per annum MSG project at a cost of Rs.26.5 crores.

1999

  • KREBS Biochemicals Ltd registered a fall in sales turnover and post-tax profit for the year ended March 31, 1999.

2002

  • Krebs Biochemicals recommended dividend at 75%.

2003

  • Krebs received FDA approval for two drugs.
  • Krebs Biochemicals received approval for 3 APIs.

2004

  • KBC and ASL entered into a pact with West Godavari Cooperative Sugar Factory Ltd.
  • Krebs Biochemicals took over possession of assets of a sugar mill in Jampani, AP.

2005

  • The company recommended dividend at 30%.

2007

  • Krebs Biochemicals designed an E-mail ID for Investor Complaints: [email protected]

2009

  • The Registered Office of the Company was shifted to 8-2-277/A, Plot No.130 , 4A, 4th Floor, Inwinex Towers, Road no.2, Banjara Hills, Hyderabad - 500034.

2014

  • The transfer agents of the Company were changed from Sathguru Management Consultants Pvt. Ltd to Karvy Computershare Pvt. Ltd.
  • Mr. R.Ch. Satyanarayana was appointed as Independent Director on the Board.

2016

  • The company shifted its registered office from Plot No.34, 8-2-577/B, 3rd Floor, Maas Heights, Road No.8, Banjara Hills, Hyderabad, Telangana- 500034 to Kothapalli Village, Kasimkota Mandal, Anakapalli, Vishakapatnam, Andhra Pradesh- 531031.

2019

  • The company issued rights shares of Rs. 10 in the ratio of 21:100 at a premium of Rs. 76 per share.

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800